Developments in technology are moving forward rapidly and over the next 50 years, healthcare across the globe will change, including an increased use of AI and robotics.
Flush with cash, Novo Nordisk Foundation now plans to reinvest some GLP-1 profits into regenerative medicines
The Novo Nordisk Foundation, the majority owner of Novo Nordisk, plans to put more money into regenerative medicines, including stem cells and cell therapies for